Wellness
July 20, 2026·5 min read
If you've been researching hormone therapy, you've almost certainly run into the word "bioidentical" — and walked away more confused than when you started. Bioidentical hormones explained in plain language is something I find myself doing in almost every hormone consultation, because the term gets used in ways that are both meaningful and misleading, often in the same sentence.
Here is what it actually means, and why the distinction matters for your care.
"Bioidentical" refers to the molecular structure of the hormone itself. Bioidentical estradiol, progesterone, and testosterone are chemically the same molecules your body has been producing since puberty. That's the whole of what the word means — structural identity.
It does not mean the hormone came from a particular source. It does not mean it was compounded rather than manufactured. It does not mean it is inherently gentler, stronger, or less risky than any other hormone preparation. The word describes molecular shape, full stop.
This matters because the term gets stretched — in marketing, in wellness content, and even sometimes in clinical settings — to imply things it cannot support. When someone tells you bioidentical hormones are automatically the better or safer choice, they are adding a layer of meaning the word does not carry. The FDA has been explicit about this: the fact that a hormone is structurally identical to an endogenous hormone does not, on its own, establish its safety or efficacy profile relative to other hormone preparations. The FDA's guidance on compounded bioidentical hormone therapy addresses this directly and is worth reading if you want the regulatory framing.
Bioidentical hormones can be FDA-approved finished pharmaceutical products, or they can be compounded by a licensed pharmacy under a 503A patient-specific prescription.
Several bioidentical hormone preparations — including certain estradiol and progesterone products — are FDA-approved. That means they have gone through the agency's formal review process for safety, efficacy, and manufacturing consistency at the doses and routes studied. When a client at Enhance uses one of these preparations, they are getting a product with an established regulatory record.
Compounded bioidentical hormones are different. They are prepared by a licensed compounding pharmacy when the commercially available FDA-approved options do not meet a specific client's clinical needs — for example, a dose that isn't available in a standard product, a delivery route that works better for a particular person, or a combination that requires custom formulation. Compounding is a legitimate and clinically useful tool. But it is not the same as an FDA-approved finished product, and I think clients deserve to understand that clearly before they start.
Compounded BHRT disclosure: When compounded hormone preparations are used in your therapy, those preparations are not FDA-approved finished pharmaceutical products. They are dispensed under 503A patient-specific prescriptions following individualized medical evaluation by Marina Roloff, DNP, FNP-C. The benefits and risks of compounded BHRT compared to FDA-approved hormone therapy have not been established by the FDA.
The Menopause Society (formerly NAMS) position on hormone therapy provides additional context on what the evidence supports across different hormone preparations — a useful reference if you are trying to sort through the clinical literature yourself.
At Enhance, BHRT is offered through multiple delivery routes: oral, sublingual, topical, injection, and EvexiPEL® hormone pellets. The route is selected based on your individual lab evaluation, your symptom picture, and your preferences — not on a one-size protocol.
EvexiPEL® pellets are one option I use frequently for clients who want consistent hormone levels without the daily variability of oral or topical dosing. Once implanted, the pellet releases hormones gradually over several months in response to your body's demands. It is not the right approach for everyone — which is precisely why the first step is always a detailed intake, not a prescription pad.
Here is what I want clients to understand about why I practice this way: I spent more than a decade in family medicine watching people describe symptoms that their labs did not explain — at least not by the reference ranges conventional medicine treats as definitive. Fatigue. Mood changes. Sleep disruption. Difficulty maintaining weight. Brain fog. These things are real, and they often have a hormonal component that standard panels miss when clinicians aren't looking at optimal ranges, only at "normal" ones.
BHRT, when indicated and carefully monitored, is a tool for addressing that gap. It is not a cure for anything. It is not appropriate for everyone. And duration of therapy is something we revisit continuously — there is no set-it-and-forget-it approach here.
Hormone therapy carries known risks including breast tenderness, fluid retention, mood changes, and — depending on regimen — cardiovascular, thromboembolic, and endometrial considerations. A face-to-face consultation, lab evaluation, and ongoing monitoring are required.
The BHRT vs. synthetic hormones question comes up in almost every consultation, so I want to address it directly.
The honest answer is that the comparison is more complicated than most content online suggests. "Synthetic" is not a single category — it encompasses a range of preparations with different molecular structures, delivery routes, and evidence bases. Some synthetic hormone preparations have decades of trial data behind them. Some bioidentical preparations have robust evidence; others have less. The research landscape is genuinely mixed, and anyone telling you one category is categorically superior is oversimplifying.
What I look at is the evidence for the specific preparation being considered, the individual client's history and risk factors, and the clinical picture in front of me. That means the answer for one person may be an FDA-approved bioidentical preparation, for another it may be a compounded formulation, and for another it may be that hormone therapy is not the right path at all — at least not yet.
The NIH's overview of hormone therapy considerations from the National Institute on Aging offers a grounded starting point if you want to read primary-source context before your consultation.
Every BHRT conversation at Enhance starts with a full intake — your symptoms, your history, your goals, and your labs. I do not prescribe based on symptoms alone, and I do not treat lab numbers that aren't connected to how you are actually feeling. Both matter.
If hormone therapy is indicated, we discuss which preparation makes sense for you — FDA-approved or compounded, which route, which hormones — and we build in a monitoring schedule from the beginning. Hormone levels are not static, and neither is the clinical picture. Follow-up is built into the care, not an afterthought.
If you are in the Yuma area and want to understand what a health and wellness consultation at Enhance actually involves, or if you have questions about the process before committing to anything, I encourage you to read through what we do before booking. The first visit is a conversation — there is no pressure to commit to anything beyond that.
You can also learn more about my clinical background and how I approach hormone therapy on my provider page.
If this resonates and you'd like to talk through what's right for you, schedule a consultation at Enhance — or call us at 928.370.4480.
"Information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary; outcomes shown or described are not guaranteed. Compounded medications referenced (including bioidentical hormone formulations) are prepared by licensed compounding pharmacies under 503A patient-specific prescriptions and are not FDA-approved finished pharmaceutical products. Consult an Enhance clinician for guidance specific to your situation. Images may contain models. © 2026 Enhance Aesthetics & Wellness."
Medically reviewed by Marina Roloff, DNP, FNP-C — 2026-07-16
Schedule a Consultation
Marina Roloff, DNP, FNP-C — Enhance Aesthetics & Wellness, Yuma, AZ
CONTACT US